Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 4

1(12.5%)

8Total

N/A(7)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT02925832Not ApplicableCompleted

Comparing Ropivacaine and Bupivacaine in DTFNB Anesthesia in Patients Undergoing Phacoemulsification

Role: lead

NCT02877940Not ApplicableCompleted

Comparison of ProSeal Laryngeal Mask Airway, LTS-D and I-gel in Mechanically Ventilated Patients

Role: lead

NCT02713685Not ApplicableCompleted

Comparison of Combined Sciatic(Winnie's) Femoral Nerve Block, and Subarachnoid Block Anesthesia for Lower Limb Surgery

Role: lead

NCT02803788Phase 4Unknown

Post-operative Nausea Vomiting in Laparoscopic Cholecystectomy

Role: lead

NCT02705794Completed

Comparison of Modified Mallampati Classification With M-TAC in Difficult Airway

Role: lead

NCT02423317Not ApplicableCompleted

Comparison of Miller's Blade and Airtraq Laryngoscope in Children

Role: lead

NCT02393677Not ApplicableCompleted

Supraclavicular Brachial Plexus Block Using Ropivacaine Alone and With Dexmedetomidine

Role: lead

NCT02513433Not ApplicableCompleted

Comparison of Levobupivacaine, Ropivacaine and Bupivacaine in Epidural Anaesthesia

Role: lead

NCT02387502Not ApplicableCompleted

Comparison of Three Laryngoscopes in Difficult Laryngoscopy

Role: lead

All 9 trials loaded